Topical astragaloside IV-releasing hydrogel improves healing of skin wounds in vivo

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 6, 2012, Pages 881-888

  Peng, Li Hua ^a   Chen, Xi ^a   Chen, Lei ^a   Li, Ni ^a   Liang, Wen Quan ^a   Gao, Jian Qing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Astragaloside IV; Hydrogel; Wound healing

Indexed keywords

ALGINIC ACID; ASTRAGALOSIDE IV; GELATIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG FORMULATION; DRUG STRUCTURE; FEMALE; HYDROGEL; IN VIVO STUDY; NONHUMAN; RAT; SKIN APPENDAGE; SKIN INJURY; SUSTAINED DRUG RELEASE; TENSILE STRENGTH; WOUND CLOSURE; WOUND HEALING;

EID: 84861862361     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.881     Document Type: Article

References (35)

1. Enoch S, Grey JE, Harding KG. Recent advances and emerging treatments. BMJ, 332, 962-965 (2006).
2. Dias AM, Braga ME, Seabra IJ, Ferreira P, Gil MH, de Sousa HC. Development of natural-based wound dressings impregnated with bioactive compounds and using supercritical carbon dioxide. Int. J. Pharm., 408, 9-19 (2011).
3. Hrynyk MG, Martins-Green M, Barron AE, Neufeld RJ. Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds. Int. J. Pharm., 398, 146-154 (2010).
4. Zhou W, Zhao M, Zhao Y, Mou Y. A fibrin gel loaded with chitosan nanoparticles for local delivery of rhEGF: preparation and in vitro release studies. J. Mater. Sci. Mater. Med., 22, 1221-1230 (2011).
5. Ashraf A, Lee PH, Kim K, Zaporojan V, Bonassar L, Valentini R, Spangenberger A, Weinzweig J. Effect of sustained-release PDGF and TGF-beta on cyclophosphamide-induced impaired wound healing. Plast. Reconstr. Surg., 124, 1118-1124 (2009).
6. Kiran S, Vijender S. Alka Arora. Natural biodegradable polymers as matrices in transdermal drug delivery. Int. J. Drug Dev. & Res., 3, 85-103 (2011).
7. Wittaya-areekul S, Kruenate J, Prahsarn C. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int. J. Pharm., 312, 113-118 (2006).
8. Sedlarik KM. What is the role of wound dressings? Med. Monatsschr. Pharm., 18, 358-362 (1995).
9. Dantas MD, Cavalcante DR, Araújo FE, Barretto SR, Aciole GT, Pinheiro AL, Ribeiro MA, Lima-Verde IB, Melo CM, Cardoso JC, Albuquerque Júnior RL. Improvement of dermal burn healing by combining sodium alginate/chitosan-based films and low level laser therapy. J. Photochem. Photobiol. B, 105, 51-59 (2011).
10. Murakami K, Ishihara M, Aoki H, Nakamura S, Nakamura S, Yanagibayashi S, Takikawa M, Kishimoto S, Yokoe H, Kiyosawa T, Sato Y. Enhanced healing of mitomycin C-treated healing-impaired wounds in rats with hydrosheets composed of chitin/chitosan, fucoidan, and alginate as wound dressings. Wound Repair Regen., 18, 478-485 (2010).
11. Suzuki Y, Tanihara M, Nishimura Y, Suzuki K, Yamawaki Y, Kudo H, Kakimaru Y, Shimizu Y. In vivo evaluation of a novel alginate dressing. J. Biomed. Mater. Res., 48, 522-527 (1999).
12. Jackson JM, Pelle M. Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance. J. Drugs Dermatol., 10, 627-633 (2011).
13. Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur. Spine J., 13 (Suppl. 1), S89-S96 (2004).
14. Rabbany SY, Pastore J, Yamamoto M, Miller T, Rafii S, Aras R, Penn M. Continuous delivery of stromal cell-derived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant., 19, 399-408 (2010).
15. Chan JY, Leung PC, Che CT, Fung KP. Protective effects of an herbal formulation of Radix Astragali, Radix Codonopsis and Cortex Lycii on streptozotocin-induced apoptosis in pancreatic beta-cells: an implication for its treatment of diabetes mellitus. Phytother. Res., 22, 190-196 (2008).
16. Lau TW, Chan YW, Lau CP, Chan CM, Lau CB, Fung KP, Leung PC, Ho YY. Investigation of the effects of Chinese medicine on fibroblast viability: implications in wound healing. Phytother. Res., 21, 938-947 (2007).
17. Lau TW, Chan YW, Lau CP, Lau KM, Lau CB, Fung KP, Leung PC, Ho YY. Radix Astragali and Radix Rehmanniae, the principal components of two antidiabetic foot ulcer herbal formulae, elicit viability-promoting effects on primary fibroblasts cultured from diabetic foot ulcer tissues. Phytother. Res., 23, 809-815 (2009).
18. Han DO, Lee HJ, Hahm DH. Wound-healing activity of Astragali Radix in rats. Methods Find. Exp. Clin. Pharmacol., 31, 95-100 (2009).
19. Chen X, Peng LH, Li N, Li QM, Li P, Fung KP, Leung PC, Gao JQ. The healing and anti-scar effects of astragaloside IV on the wound repair in vitro and in vivo. J. Ethnopharmacol., 139, 721-727 (2012).
20. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature, 453, 314-321 (2008).
21. Stephan B, Olivera S, Michael S, Harold Brem, Marjana TC. Growth factors and cytokines in wound healing. Wound Rep. Reg., 16, 585-601 (2008).
22. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev., 83, 835-870 (2003).
23. Zhang Q, Zhu LL, Chen GG, Du Y. Pharmacokinetics of astragaloside IV in beagle dogs. Eur. J. Drug Metab. Pharmacokinet., 32, 75-79 (2007).
24. Lauto A, Hook J, Doran M, Camacho F, Poole-Warren LA, Avolio A, Foster LJ. Chitosan adhesive for laser tissue repair: in vitro characterization. Lasers Surg. Med., 36, 193-201 (2005).
25. Li C, Gotlieb AI. Transforming Growth Factor-β Regulates the Growth of Valve Interstitial Cells in Vitro. Am. J. Pathol., 179, 1746-1755 (2011).
26. Yeom J, Bhang SH, Kim BS, Seo MS, Hwang EJ, Cho IH, Park JK, Hahn SK. Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration. Bioconjug. Chem., 21, 240-247 (2010).
27. Rashed AN, Afifi FU, Disi AM. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J. Ethnopharmacol., 88, 131-136 (2003).
28. Horch RE, Kopp J, Kneser U, Beier J, Bach AD. Tissue engineering of cultured skin substitutes. J. Cell. Mol. Med., 9, 592-608 (2005).
29. Bordenave L, Caix J, Basse-Cathalinat B, Baquey C, Midy D, Baste JC, Constans H. Experimental evaluation of a gelatin-coated polyester graft used as an arterial substitute. Biomaterials, 10, 235-242 (1989).
30. Kuo CK, Ma PX. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials, 22, 511-521 (2001).
31. Balakrishnan B, Mohanty M, Umashankar PR, Jayakrishnan A. Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials, 26, 6335-6342 (2005).
32. Choi YS, Hong SR, Lee YM, Song KW, Park MH, Nam YS. Study on gelatin-containing artificial skin: I. Preparation and characteristics of novel gelatin-alginate sponge. Biomaterials, 20, 409-417 (1999).
33. Raymond J, Metcalfe A, Desfaits AC, Ribourtout E, Salazkin I, Gilmartin K, Embry G, Boock RJ. Alginate for Endovascular Treatment of Aneurysms and Local Growth Factor Delivery. Am. J. Neuroradiol., 24, 1214-1221 (2003).
34. Sevimli-Gür C, Onbaşilar I, Atilla P, Genç R, Cakar N, Deliloǧlu- Gürhan I, Bedir E. In vitro growth stimulatory and in vivo wound healing studies on cycloartane-type saponins of Astragalus genus. J. Ethnopharmacol., 134, 844-850 (2011).
35. Zambruno G, Marchisio PC, Marconi A, Vaschieri C, Melchiori A, Giannetti A, De Luca M. Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. J. Cell Biol., 129, 853-865 (1995).